Document

Filter documents

pdf icon

FSRH Clinical Guideline: Progestogen-only Implant (February 2021, Amended July 2023)

File size: 1450kb | Date: 17 July 2023 | Current Clinical Guidance - PDF

pdf icon

FSRH Clinical Guideline: Intrauterine contraception (March 2023, Amended July 2023)

File size: 2657kb | Date: 17 July 2023 | Current Clinical Guidance - PDF

The guideline provides evidence-based recommendations and good practice points to enable clinicians to support individuals to make informed decisions about choosing and using IUC. It includes information on assessing suitability of IUC use for contraception, the risks and benefits of IUC and guidance for IUC procedures, complications and follow-up. Published March 2023.

Please read this guidance document in conjunction with any relevant clinical statements for this topic:

FSRH CEU Statement: Response to new study by Meaidi et al (2023) Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs (September 2023)

FSRH Response to new study on use of CHC and POC and breast cancer risk (March 2023)

FSRH CEU Response to published study: Maternal use of hormonal contraception and risk of childhood leukemia: a nationwide, populate-based cohort study (September 2018)

FSRH CEU Statement to published systematic review: The relationship between progestin hormonal contraception and depression: a systematic review (March 2018)

FSRH CEU Statement: Response to Study Contemporary Hormonal Contraception and the Risk of Breast Cancer (December 2017)

FSRH CEU Statement: Response to Study: Intrauterine Contraception Use and Cervical Cancer Risk (January 2018)

FSRH CEU Statement: Contraception and Weight Gain (August 2019)


The digital version can be accessed from the BMJ SRH website: FSRH Guideline (March 2023) Intrauterine contraception BMJ Sexual & Reproductive Health 2023;49:1-142. 

pdf icon

FSRH Clinical Guideline: Progestogen-only Pills (August 2022, Amended July 2023)

File size: 1690kb | Date: 17 July 2023 | Current Clinical Guidance - PDF

pdf icon

FSRH CEU Guidance: Progestogen-only Pills Quick Reference Summary (August 2022, updated July 2023)

File size: 482kb | Date: 17 July 2023 | Current Clinical Guidance - PDF

This summary has been written as a quick reference guide to help busy clinicians to give clear, safe advice on progestogen-only contraceptive pills. Please refer to the full 2022 FSRH Progestogen-only Pills Clinical Guideline for further information and supporting evidence for this advice. This document is written for FSRH members and requires you to log in to access it.

pdf icon

FSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended July 2023)

File size: 1824kb | Date: 17 July 2023 | Current Clinical Guidance - PDF

pdf icon

FSRH Clinical Guideline: Combined Hormonal Contraception (January 2019, Amended October 2023)

File size: 1297kb | Date: 13 July 2023 | Current Clinical Guidance - PDF

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of combined hormonal contraceptives (i.e. the combined oral contraceptive pill, transdermal patch and combined vaginal ring) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

Please read this guidance document in conjunction with any relevant clinical statements for this topic:

FSRH CEU Statement: Response to new study by Meaidi et al (2023) Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs (September 2023)

FSRH Response to new study on use of CHC and POC and breast cancer risk (March 2023)

FSRH CEU Statement: New manufacturer/MHRA advice regarding nomegestrol acetate – how does this affect prescribing of Zoely®? (April 2023)

FSRH CEU Statement : New advice from the MHRA regarding cyproterone acetate: how does this affect prescribing of Co-cyprindiol/Dianette® for acne/hirsutism? July 2020

FSRH CEU Response to published study: Maternal use of hormonal contraception and risk of childhood leukemia: a nationwide, populate-based cohort study (September 2018)

FSRH CEU Statement: Oral Contraceptives and Multiple Sclerosis (March 2014)

FSRH CEU Statement: Response to Study Contemporary Hormonal Contraception and the Risk of Breast Cancer (December 2017)

FSRH CEU Statement: Contraception and Weight Gain (August 2019)

FSRH CEU Statement: Response to new reports of link between COC and Glaucoma (November 2013)


The digital version can be accessed from the BMJ SRH website: FSRH Guideline (January 2019, amended November 2020) Combined Hormonal Contraception. BMJ Sexual & Reproductive Health 2019; 45:Suppl 1.

docx icon

LoC SDI-IR Syllabus

File size: 200kb | Date: 5 July 2023 | Current Clinical Guidance - DOCX

LoC SDI-IR Syllabus. Download and save. 

pdf icon

Certificate of Attendance - ASM 2023

File size: 77kb | Date: 5 July 2023 | Current Clinical Guidance - PDF

Here you can download a copy of the Certificate of Attendance for the Annual Scientific Meeting (ASM) 2023: Visions for the Future. As stated on the certificate, this event is worth a total of 8 CPD points.